More than 10 percent of severe COVID-19 patients have antibodies that attack type I interferon instead of the virus, according to a study published in Science Sept. 24. (Photo courtesy of COL Kevin Chung)
Date Taken: | 04.22.2020 |
Date Posted: | 09.24.2020 14:11 |
Photo ID: | 6361811 |
VIRIN: | 200422-D-ZZ999-003 |
Resolution: | 1600x1200 |
Size: | 371.29 KB |
Location: | US |
Web Views: | 8 |
Downloads: | 3 |
This work, Genetic, immunological abnormalities in Type I interferon pathway are risk factors for severe COVID-19 [Image 3 of 3], must comply with the restrictions shown on https://www.dvidshub.net/about/copyright.